#272 ‒ Rapamycin: potential longevity benefits, surge in popularity, unanswered questions, and more | David Sabatini, M.D., Ph.D. and Matt Kaeberlein, Ph.D.
“[Rapamycin] is the most robust and reproducible drug that we know about today for impacting not only longevity, but to the extent that we can measure various metrics of healthspan in complex animals, rapamycin also seems to positively impact pretty much every aspect of health span that we measure.” —Matt Kaeberlein
#217 ‒ Exercise, VO2 max, and longevity | Mike Joyner, M.D.
“The idea is to live a long time and then die quickly with minimal disability.” —Mike Joyner
Alcohol, sleep, and stress: A self-fulfilling prophecy
This audio clip is from our sleep series with Matthew Walker, Ph.D., episode #126 — Matthew Walker, Ph.D.: Sleep and…
Not another COVID newsletter
In last week’s newsletter on vaccine mandates, I implored you all to think. Many of you rose to the occasion with insightful feedback.
#192 – COVID Part 2: Masks, long COVID, boosters, mandates, treatments, and more
“I think people are starving out there for honesty on this topic that’s not tribal” – Marty Makary
Why I’m for COVID vaccines, but against vaccine mandates.
In the heated debate over vaccine mandates, science and logic have often been lost amid politics and fear.
#189 – COVID Part 1: Current state of affairs, Omicron, and a search for the end game
“Where’s the humility? People are hungry for honesty right now.” —Marty Makary